SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+1.84%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.59B
AUM Growth
+$1.59B
(-1.7%)
Cap. Flow
+$31.4M
Cap. Flow
% of AUM
1.98%
Top 10 Holdings %
Top 10 Hldgs %
62.27%
Holding
81
New
13
Increased
16
Reduced
16
Closed
16
Top Buys
| 1 |
Bolt Biotherapeutics
BOLT
|
$90.6M |
| 2 |
Eli Lilly
LLY
|
$26.8M |
| 3 |
NextCure
NXTC
|
$26.7M |
| 4 |
Align Technology
ALGN
|
$24.6M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$23.6M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$75.8M |
| 2 |
AbbVie
ABBV
|
$31.5M |
| 3 |
Amgen
AMGN
|
$31.3M |
| 4 |
United Therapeutics
UTHR
|
$22.2M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$14.4M |
Sector Composition
| 1 | Healthcare | 97.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OBSV
26
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $15.4M | 0.93% |
4,749,623
| – | – |
|
27
uniQure
QURE
$954M
| $14.4M | 0.87% |
+427,122
| New | +$14.4M |
|
28
Regenxbio
RGNX
$498M
| $12.3M | 0.74% |
361,735
+90,621
| +33% | +$3.09M |
|
|
HZNP
29
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $12.3M | 0.74% |
133,997
-79,393
| -37% | -$7.31M |
|
30
Vertex Pharmaceuticals
VRTX
$102B
| $9.82M | 0.59% |
+45,700
| New | +$9.82M |
|
31
DexCom
DXCM
$30.9B
| $9.7M | 0.58% |
+108,000
| New | +$9.7M |
|
|
32
Amgen
AMGN
$153B
| $9.67M | 0.58% |
38,868
-125,795
| -76% | -$31.3M |
|
|
AGEN
33
Agenus
AGEN
$136M
| $9.46M | 0.57% |
+177,214
| New | +$9.46M |
|
34
Mirum Pharmaceuticals
MIRM
$3.75B
| $9.44M | 0.57% |
476,401
+21,427
| +5% | +$425K |
|
35
Athira Pharma
ATHA
$15.5M
| $9.37M | 0.56% |
509,168
| – | – |
|
|
CCXI
36
DELISTED
ChemoCentryx, Inc.
CCXI
| $9.22M | 0.55% |
179,999
+66,786
| +59% | +$3.42M |
|
37
Cytokinetics
CYTK
$5.98B
| $9.07M | 0.55% |
389,720
-118,674
| -23% | -$2.76M |
|
|
TCRR
38
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $7.43M | 0.45% |
336,682
+2,975
| +0.9% | +$65.7K |
|
|
AMRN
39
Amarin Corp
AMRN
$311M
| $7.27M | 0.44% |
58,529
| – | – |
|
40
Syndax Pharmaceuticals
SNDX
$1.39B
| $6.68M | 0.4% |
298,644
-74,265
| -20% | -$1.66M |
|
41
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $6.35M | 0.38% |
434,555
| – | – |
|
|
ARNA
42
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $6.35M | 0.38% |
91,448
-29,925
| -25% | -$2.08M |
|
|
MRNS
43
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $5.73M | 0.34% |
370,351
+96,324
| +35% | +$1.49M |
|
|
JNCE
44
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $5.26M | 0.32% |
511,822
-413,458
| -45% | -$4.25M |
|
45
Insulet
PODD
$24.2B
| $4.57M | 0.27% |
+17,500
| New | +$4.57M |
|
46
Fate Therapeutics
FATE
$115M
| $4.52M | 0.27% |
54,795
+41,298
| +306% | +$3.41M |
|
47
Replimune Group
REPL
$460M
| $4.34M | 0.26% |
142,209
+122,209
| +611% | +$3.73M |
|
48
Immatics
IMTX
$662M
| $4.32M | 0.26% |
385,099
+105,567
| +38% | +$1.18M |
|
49
Aligos Therapeutics
ALGS
$75.1M
| $4.22M | 0.25% |
7,421
-221
| -3% | -$126K |
|
|
APTO
50
DELISTED
Aptose Biosciences, Inc.
APTO
| $4.16M | 0.25% |
1,549
-631
| -29% | -$1.7M |
|